New targets for the development of PET tracers for imaging neurodegeneration in Alzheimer disease

Journal of Nuclear Medicine

Volumn 55, Issue 8, 2014, Pages 1221-1224

  Mach, Robert H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Neuroinflammation; Oxidative stress; Secretase

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MULTIDRUG RESISTANCE PROTEIN; TRACER;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; BLOOD BRAIN BARRIER; COGNITIVE DEFECT; HUMAN; INTRACELLULAR SIGNALING; MOLECULAR IMAGING; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROBIOLOGY; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CLEAVAGE; ANIMAL; BRAIN; DISEASE COURSE; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; SCINTISCANNING;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; DISEASE PROGRESSION; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS;

EID: 84905502254     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.114.127811     Document Type: Article

References (25)

1. Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012;367:795-804.
2. Vlassenko AG, Benzinger TL, Morris JC. PET amyloid-beta imaging in preclinical Alzheimer's disease. Biochim Biophys Acta. 2012;1822:370-379.
3. Chien DT, Szardenings AK, Bahri S, et al. Early clinical PET imaging results with the novel PHFtau radioligand [18F]T808. J Alzheimers Dis. 2014;38:171-184.
4. Okamura N, Furumoto S, Harada R, et al. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease. J Nucl Med. 2013;54:1420-1427.
5. Xia CF, Arteaga J, Chen G, et al. [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. Alzheimers Dement. 2013;9:666-676.
6. Maruyama M, Shimada H, Suhara T, et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron. 2013;79:1094-1108.
7. Medeiros R, Chabier MA, LaFerla FM. Elucidating the triggers, progression, and effects of Alzheimer's disease. J Alzheimers Dis. 2013;33(suppl):S195-S210.
8. Yan R, Vassar R. Targeting the β secretase BACE1 for Alzheimer's disease therapy. Lancet Neurol. 2014;13:319-329.
9. Erickson MA, Banks WA. Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J Cereb Blood Flow Metab. 2013;33:1500-1513.
10. Castellano JM, Kim J, Stewart FR, et al. Human apoE isoforms differentially regulate brain amyloid b peptide clearance. Science Trans Med. 2011;3:89ra57.
11. Jeynes B, Provias J. P-glycoprotein altered expression in Alzheimer's disease: regional anatomic variability. J Neurodegen Disord. 2013: article ID, 257953.
12. van Assema DME, Lubberink M, Bauer M, et al. Blood-brain barrier P-glycoprotein function in Alzheimer's disease. Brain. 2012;135:181-189.
13. Esparza TJ, Zhao H, Cirrito JR, et al. Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls. Ann Neurol. 2013;73:104-119.
14. Mucke L, Selkoe DJ. Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med. 2012;2:a006338.
15. Wang L, Chang H-C, Wu W, et al. Epidermal growth factor receptor is a preferred target for treating amyloid β-induced memory loss. Proc Natl Acad Sci USA. 2012;109:16743-16748.
16. Kim T, Vidal GS, Djurisic M, et al. Human LilrB2 is a b-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model. Science. 2013;341:1399-1404.
17. Kanekiyo T, Cirrito JR, Liu C-C, et al. Neuronal clearance of amyloid-b by endocytic receptor LRP1. J Neurosci. 2013;33:19276-19283.
18. Graeber MB. Changing face of microglia. Science. 2010;330:783-788.
19. London A, Cohen M, Schwartz M. Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair. Front Cell Neurosci. 2013;7:34.
20. Solito E, Sastre M. Microglia function in Alzheimer's disease. Front Pharmacol. 2012;3:14.
21. Glass CK, Saijo K, Winner B, et al. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140:918-934.
22. Jacobs AH, Tavitian B; INMiND consortium. Noninvasive imaging of neuroinflammation. J Cereb Blood Flow Metab. 2012;32:1393-1415.
23. Scarf AM, Kassiou M. The translocator protein. J Nucl Med. 2011;52:677-680.
24. Owen DR, Gunn RN, Rabiner EA, et al. Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med. 2011;52:24-32.
25. Frisoni GB. Biomarker trajectories across stages of Alzheimer disease. Nat Rev Neurol. 2012;8:299-300.